Reaction
Growth Hormone-Producing Pituitary Tumour reporting signals
As of the last recalculation, Growth Hormone-Producing Pituitary Tumour appears in 32 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is PRIMIDONE (PRR 1,802.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Primidone | 15 | 1,802.0 | 1,804.7 |
| Atomoxetine Hydrochloride | 14 | 679.4 | 679.8 |